Literature DB >> 19427924

Further genetic evidence suggesting a role for the RhoGTPase-RhoGEF pathway in osteoporosis.

Ben H Mullin1, Richard L Prince, Cyril Mamotte, Tim D Spector, Deborah J Hart, Frank Dudbridge, Scott G Wilson.   

Abstract

Osteoporosis is a highly heritable trait that appears to be influenced by multiple genes. Genome-wide linkage studies have highlighted the chromosomal region 3p14-p21 as a quantitative trait locus for BMD. We have previously published evidence suggesting that the ARHGEF3 gene from this region is associated with BMD in women. The product of this gene activates the RHOA GTPase, the gene for which is also located within this region. The aim of this study was to evaluate the influence of genetic polymorphism in RHOA on bone density in women. Sequence variation within the RHOA gene region was determined using 9 single nucleotide polymorphisms (SNPs) in a discovery cohort of 769 female sibs. Of the 9 SNPs, one was found to be monomorphic with the others representing 3 distinct linkage disequilibrium (LD) blocks. Using FBAT software, significant associations were found between two of these LD blocks and BMD Z-score of the spine and hip (P=0.001-0.036). The LD block tagged by the SNP rs17595772 showed maximal association, with the more common G allele at rs17595772 associated with decreased BMD Z-score. Genotyping for rs17595772 in a replication cohort of 780 postmenopausal women confirmed an association with BMD Z-score (P=0.002-0.036). Again, the G allele was found to be associated with a reduced hip and spine BMD Z-score. These results support the implication of the RhoGTPase-RhoGEF pathway in osteoporosis, and suggest that one or more genes in this pathway may be responsible for the linkage observed between 3p14-p21 and BMD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427924     DOI: 10.1016/j.bone.2009.04.254

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  12 in total

1.  Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA.

Authors:  Jun Wang; Paula H Stern
Journal:  J Cell Biochem       Date:  2010-12-15       Impact factor: 4.429

Review 2.  Genetic epidemiology of age-related osteoporosis and its clinical applications.

Authors:  Ching-Lung Cheung; Su-Mei Xiao; Annie W C Kung
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

3.  Population genomics of parallel adaptation in threespine stickleback using sequenced RAD tags.

Authors:  Paul A Hohenlohe; Susan Bassham; Paul D Etter; Nicholas Stiffler; Eric A Johnson; William A Cresko
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

Review 4.  Genetics of osteoporosis: accelerating pace in gene identification and validation.

Authors:  Wen-Feng Li; Shu-Xun Hou; Bin Yu; Meng-Meng Li; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2009-12-12       Impact factor: 4.132

5.  Conditional testing of multiple variants associated with bone mineral density in the FLNB gene region suggests that they represent a single association signal.

Authors:  Benjamin H Mullin; Cyril Mamotte; Richard L Prince; Tim D Spector; Frank Dudbridge; Scott G Wilson
Journal:  BMC Genet       Date:  2013-10-31       Impact factor: 2.797

6.  Influence of ARHGEF3 and RHOA knockdown on ACTA2 and other genes in osteoblasts and osteoclasts.

Authors:  Benjamin H Mullin; Cyril Mamotte; Richard L Prince; Scott G Wilson
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

7.  Genome-wide association study using family-based cohorts identifies the WLS and CCDC170/ESR1 loci as associated with bone mineral density.

Authors:  Benjamin H Mullin; John P Walsh; Hou-Feng Zheng; Suzanne J Brown; Gabriela L Surdulescu; Charles Curtis; Gerome Breen; Frank Dudbridge; J Brent Richards; Tim D Spector; Scott G Wilson
Journal:  BMC Genomics       Date:  2016-02-25       Impact factor: 3.969

8.  Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway.

Authors:  Mengrui Wu; Wei Chen; Yun Lu; Guochun Zhu; Liang Hao; Yi-Ping Li
Journal:  Nat Commun       Date:  2017-01-19       Impact factor: 14.919

Review 9.  Molecular Mechanisms and Emerging Therapeutics for Osteoporosis.

Authors:  Ji-Yoon Noh; Young Yang; Haiyoung Jung
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

10.  Gene-set based genome-wide association analysis for the speed of sound in two skeletal sites of Korean women.

Authors:  Ji-Sun Kwon; Sangsoo Kim
Journal:  BMB Rep       Date:  2014-06       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.